FLNA
Filana Therapeutics, Inc.Company with tickers: FLNA
CIK
1069530
CUSIP
14817C107
Shares Outstanding
48,307,896
13F Activity (30d)
75 filings
73 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2024-05-08 | — | |
| 8-K | 2024-05-01 | — | |
| 8-K | 2024-04-15 | — | |
| 10-K | 2024-02-28 | 2023-12-31 | |
| 8-K | 2024-02-28 | — | |
| 8-K | 2024-02-07 | — | |
| 8-K | 2024-01-03 | — | |
| 8-K | 2023-12-12 | — | |
| 8-K | 2023-12-11 | 2023-12-06 | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-11-07 | — | |
| 8-K | 2023-09-13 | 2023-09-08 | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 8-K | 2023-08-03 | — | |
| 8-K | 2023-07-05 | — | |
| 8-K | 2023-05-08 | 2023-05-04 | |
| 8-K | 2023-05-01 | 2023-04-26 | |
| 8-K | 2023-05-01 | — | |
| 10-Q | 2023-05-01 | 2023-03-31 | |
| 8-K | 2023-03-17 | 2023-03-16 | |
| 8-K | 2023-03-10 | — | |
| 10-K | 2023-02-28 | 2022-12-31 | |
| 8-K | 2023-02-28 | — | |
| 8-K | 2023-01-24 | — | |
| 8-K | 2022-12-22 | 2022-12-19 | |
| 8-K | 2022-11-22 | 2022-11-18 | |
| 10-Q | 2022-11-07 | 2022-09-30 | |
| 8-K | 2022-11-07 | — | |
| 8-K | 2022-11-03 | — | |
| 8-K | 2022-10-27 | 2022-10-13 | |
| 8-K | 2022-09-23 | 2022-09-22 | |
| 10-Q | 2022-08-04 | 2022-06-30 | |
| 8-K | 2022-08-03 | — | |
| 8-K | 2022-05-09 | 2022-05-05 | |
| 10-Q | 2022-05-05 | 2022-03-31 | |
| 8-K | 2022-05-05 | — | |
| 8-K | 2022-04-26 | — | |
| 10-K | 2022-03-01 | 2021-12-31 | |
| 8-K | 2022-02-28 | — | |
| 8-K | 2022-01-06 | 2022-01-05 | |
| 10-Q | 2021-11-15 | 2021-09-30 | |
| 8-K | 2021-11-10 | — | |
| 10-Q | 2021-08-04 | 2021-06-30 | |
| 8-K | 2021-08-03 | 2021-07-29 | |
| 8-K | 2021-08-03 | — | |
| 8-K | 2021-06-21 | — | |
| 8-K | 2021-06-14 | — | |
| 8-K | 2021-05-06 | — | |
| 10-Q | 2021-04-29 | 2021-03-31 | |
| 8-K | 2021-04-21 | — |
Showing 51–100 of 125 filings